Taken together, these findings revealed that NR2F6 might play an important immunosuppressive role in glioma through recruiting and promoting immunosuppressive cells to secrete immune-inhibitory cytokines, as well as regulating M2 transformation. The gene discussed is NR2F6; the disease is central nervous system cancer.